Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Efficacité traitement And NotJ. D. Speelman

List of bibliographic references

Number of relevant bibliographic references: 35.
Ident.Authors (with country if any)Title
002414 Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis]Long-term outcome of quetiapine use for psychosis among parkinsonian patients
002415 Stig Rehncrona [Suède] ; Bo Johnels [Suède] ; Hakan Widner [Suède] ; Anna-Lena Törnqvist [Suède] ; Marwan Hariz [Suède] ; Olof Sydow [Suède]Long-term efficacy of Thalamic deep brain stimulation for tremor: Double-blind assessments
002467 Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study
002472 Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of Levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure
002478 Francesca Mancini [Italie] ; Roberta Zangaglia [Italie] ; Silvano Cristina [Italie] ; Maria Grazia Sommaruga [Italie] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Claudio Pacchetti [Italie]Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of Drooling in parkinsonism
002513 Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
002963 William C. Koller [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Troster [États-Unis] ; Rajesh Pahwa [États-Unis]Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor
002A11 N. Allert [Allemagne] ; J. Volkmann [Allemagne] ; S. Dotse [Allemagne] ; H. Hefter [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne]Effects of Bilateral pallidal or subthalamic stimulation on gait in advanced Parkinson's Disease
002C98 S. A. Factor [États-Unis] ; E. S. Molho [États-Unis]Transient benefit of amantadine in Parkinson's disease : The facts about the myth
002E21 A. S.-I. Pakiam [Canada] ; A. E. Lang [Canada]Essential palatal tremor : Evidence of heterogeneity based on clinical features and response to sumatriptan
002F05 R. Lindeboom [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; M. Aramideh [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; R. J. De Haan [Pays-Bas]Treatment of cervical dystonia : A comparison of measures for outcome assessment
003152 M. Zappia [Italie] ; R. Montesanti [Italie] ; R. Colao [Italie] ; D. Branca [Italie] ; G. Nicoletti [Italie] ; U. Aguglia [Italie] ; A. Quattrone [Italie]Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease
003310 J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Treatment of nonoccupational limb and trunk dystonia with botulinum toxin
003314 M. Raja [Italie] ; G. Maisto [Italie] ; M. C. Altavista [Italie] ; A. Albanese [Italie]Tardive lingual dystonia treated with clozapine
003324 G. K. Wenning [Royaume-Uni] ; R. Granata [Italie] ; P. M. Laboyrie [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration
003333 A. Freese [États-Unis] ; M. Stern [États-Unis] ; M. G. Kaplitt ; W. M. O'Connor [États-Unis] ; M. V. Abbey ; M. J. O'Connor [États-Unis] ; M. J. During [États-Unis]Prospects for gene therapy in Parkinson's disease
003335 F. Picard [France] ; A. De Saint-Martin [France] ; E. Salmon [Belgique] ; E. Hirsch [France] ; C. Marescaux [France]Postencephalitic stereotyped involuntary movements responsive to L-Dopa
003336 R. Pahwa [États-Unis] ; J. Marjama [États-Unis] ; D. Mcguire [États-Unis] ; K. Lyons [États-Unis] ; F. Zwiebel ; P. Silverstein ; R. Ward ; W. C. Koller [États-Unis]Pharmacokinetic comparison of Sinemet and atamet (generic carbidopa/levodopa) : A single-dose study
003357 B. R. Bloem [Pays-Bas] ; D. J. Beckley [États-Unis] ; J. G. Van Dijk [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; M. P. Remler [États-Unis] ; R. A. C. Roos [Pays-Bas]Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease
003358 C. Geny [France] ; J.-P. Nguyen [France] ; B. Pollin [France] ; A. Feve [France] ; F. Ricolfi [France] ; P. Cesaro [France] ; J.-D. Degos [France]Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation
003397 G. Geminiani [Italie] ; V. Fetoni [Italie] ; S. Genitrini [Italie] ; P. Giovannini [Italie] ; F. Tamma [Italie] ; T. Caraceni [Italie]Cabergoline in Parkinson's disease complicated by motor fluctuations
003401 G. W. Paulson [États-Unis] ; W. Gill [États-Unis]Botulinum toxin is unsatisfactory therapy for fibromyalgia
003402 B. L. Scott [États-Unis] ; Joseph Jankovic [États-Unis] ; D. T. DonovanBotulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
003424 N. G. Ranen [États-Unis] ; C. E. Peyser [États-Unis] ; J. T. Coyle [États-Unis] ; F. W. Bylsma [États-Unis] ; M. Sherr [États-Unis] ; L. Day [États-Unis] ; M. F. Folstein [États-Unis] ; J. Brandt [États-Unis] ; C. A. Ross [États-Unis] ; S. E. Folstein [États-Unis]A controlled trial of idebenone in Huntington's disease
003462 T. Van Laar [Pays-Bas] ; E. N. H. Jansen ; C. Neef ; M. Danhof ; R. A. C. RoosPharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease : a study of five different suppositories
003480 R. Inzelberg [Israël] ; P. Nisipeanu ; M. J. Rabey ; A. D. KorczynLong-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
003505 R. Cole [États-Unis] ; M. Hallett ; L. G. CohenDouble-blind trial of botulinum toxin for treatment of focal hand dystonia
003519 M. H. Mark [États-Unis] ; J. I. Sage ; A. S. Walters ; R. C. Duvoisin ; D. C. MillerBinswanger's disease presenting as levodopa-responsive parkinsonism : clinicopathologic study of three cases
003588 G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. MoscarelliPergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study
003623 K. B. Polo [États-Unis] ; BAHMAN JABBARIEffectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin
003648 C. W. Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J. D. Grimes ; Joseph Jankovic [États-Unis] ; M. Hoehn ; C. H. Markham ; R. Duvoisin ; O. Reinmuth ; H. A. Leonard ; E. Ahlskog ; R. Feldman ; L. Hershey ; M. D. YahrA multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease
003853 J.-P. Stübgen [Afrique du Sud] ; B. P. LotzSegmental ballistic movement overflow myoclonus : a clinical, electromyographic and pharmacologic evaluation
003954 U. J. Povlsen ; H. PakkenbergEffect of intravenous injection of biperiden and clonazepam in dystonia
003A14 R. F. Pfeiffer ; L. H. Herrera ; C. S. Glaeske ; R. E. HofmanCQP A01-403 in Parkinson's disease: an open-label pilot study
003A27 D. Dung Truong ; S. FahnTherapeutic trial with glycine in myoclonus

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024